Episode
Understanding Fatty Liver
- Podcast
- Dr. Joe Galati Podcast
- Published
- Apr 28, 2025
- Duration seconds
- 1245
- Processing state
not_requested- Canonical source
- https://shows.acast.com/the-dr-joe-galati-podcast/episodes/understanding-fatty-liver
Actions
POST https://stenobird.com/v1/public/podcasts/dr-joe-galati-podcast-1172429/episodes/understanding-fatty-liver/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-joe-galati-podcast-1172429/understanding-fatty-liver.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to this episode of the Dr. Joe Galati Podcast where we delve into pressing health issues and the latest medical advancements. Today, we have a special guest, Dr. Mazen Noureddin , a world-renowned liver researcher, who joins us for an enlightening conversation about metabolic dysfunction associated with fatty liver disease, a condition that has become a public health crisis globally. As obesity and sedentary lifestyles continue to rise, the prevalence of fatty liver disease has skyrocketed, affecting millions of people worldwide. In this episode, we take a deep dive into the global epidemic of fatty liver disease , also known as metabolic dysfunction associated steatotic liver disease (MASLD). Dr. Noureddin sheds light on alarming statistics: nearly one in four adults globally suffers from this condition, which can lead to serious liver complications. We discuss how fatty liver disease often accompanies other metabolic disorders, such as type 2 diabetes, hypertension, and elevated cholesterol levels, creating a complex web of health challenges for affected individuals. The conversation touches upon the epidemiology of fatty liver disease, exploring how socioeconomic factors and lifestyle choices contribute to its rapid proliferation. Dr. Noureddin explains the disease's natural history, detailing how it can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), cirrhosis, and even liver cancer. We discuss the critical importance of early diagnosis and risk assessment, as many individuals remain asymptomatic until the disease reaches advanced stages. Furthermore, our discussion highlights the increasing need for liver transplants due to the progression of fatty liver disease complications. Dr. Noureddin shares breakthroughs in research and poten…